2 sources retrieved · Most recent: April 2026 · Index updated 15 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
19PubMed Papers
19Diseases
0Drugs
0Pathogenic Variants
DATA QUALITY✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
protein bindingkinase bindingnegative regulation of toll-like receptor signaling pathwaycytoplasmattention deficit hyperactivity disorderintelligencerisk-taking behaviourmathematical ability
Based on limited published evidence, LRRC14 is a leucine-rich repeat protein that functions as a negative regulator of Toll-like receptor-mediated NF-κB signaling. LRRC14 attenuates inflammatory responses by binding to the HLH domain of IKBKB, disrupting IKK core complex formation and preventing NF-κB phosphorylation and activation 1. The gene is subject to complex regulation involving bidirectional promoter control and alternative splicing 2. LRRC14 operates as a checkpoint mechanism to prevent excessive inflammation while maintaining innate immune responses.
1
LRRC14 negatively regulates TLR-mediated NF-κB signaling by binding IKBKB and disrupting IKK complex formation, preventing inflammatory cytokine production
PMID: 274267252
LRRC14 expression is regulated by an evolutionary conserved bidirectional promoter shared with RECQL4, involving multiple promoters and alternative splicing with tissue-specific expression patterns
PMID: 19720120⚠Limited data available — This gene has 2 indexed publications. Summary and analysis may be incomplete.
attention deficit hyperactivity disorderOpen Targets
risk-taking behaviourOpen Targets
mathematical abilityOpen Targets
musculoskeletal system diseaseOpen Targets
joint diseaseOpen Targets
Dravet syndromeOpen Targets
osteoarthritis, hipOpen Targets
familial atrioventricular septal defectOpen Targets
HistiocytosisOpen Targets
cervical cancerOpen Targets
gastric cancerOpen Targets
nonpapillary renal cell carcinomaOpen Targets
ovarian serous cystadenocarcinomaOpen Targets
uterine corpus endometrial carcinomaOpen Targets
No pathogenic variants reported on ClinVar for this gene.